Cost valuation in resource-poor settings

Health Policy and Planning

Volumn 20, Issue 4, 2005, Pages 252-259

  Hutton, Guy ^a   Baltussen, Rob ^b,c  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cost valuation; Cost effectiveness analysis; Developing countries; Economic evaluation; Transferability

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; HEALTH CARE COST; HEALTH CARE FACILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSURANCE; MANPOWER; PROFIT; REVIEW; TUBERCULOSIS; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

COSTS AND COST ANALYSIS; DEVELOPING COUNTRIES; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY;

EID: 21744457233     PISSN: 02681080     EISSN: None     Source Type: Journal    
DOI: 10.1093/heapol/czi025     Document Type: Review

References (26)

1. Adam T, Evans D, Murray C. 2003. Econometric estimation of country-specific hospital costs. Cost-effectiveness and Resource Allocation 1: 3.
2. Asian Development Bank. 1997. Guidelines for the economic analysis of projects. Manila: Asian Development Bank, Economics and Development Resource Center.
3. Bryan S, Brown J. 1998. Extrapolation of cost-effectiveness information to local settings. Journal of Health Services Research and Policy 3: 108-12.
4. Creese A, Parker D. 1994. Cost analysis in primary health care: a training manual for programme managers. Geneva: World Health Organization.
5. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. 1997. Methods for the economic evaluation of health care programmes, 2nd Edition. Oxford: Oxford University Press.
6. Gittinger J. 1984. Economic analysis of agricultural projects. Baltimore, MD: John Hopkins Press.
7. Gold MR, Siegel JE, Russell LB, Weinstein MC. 1996. Cost-effectiveness in health and medicine. Oxford: Oxford University Press.
8. Hughes G. 1986. Conversion factors and shadow exchange rates. Project Appraisal 1: 106-20.
9. Hutton G, Fox Rushby J, Mugford M et al. 2004. Examining within-country variation of maternity costs in the context of a multicountry, multicentre randomised controlled trial. Applied Health Economics and Health Policy 3: 161-70.
10. Johns B, Baltussen R, Hutubessy R. 2002. Programme costs in the economic evaluation of interventions. Cost-Effectiveness and Resource Allocation 1: 1.
11. Koopmanschap M, Rutten F, van Ineveld B, van Roijen L. 1995. The friction cost method for measuring indirect costs of disease. Journal of Health Economics 14: 171-89.
12. Kumaranayake L, Pepperall J, Goodman H, Mills A, Walker D. 2000. Costing guidelines for HIV/AIDS prevention strategies. UNAIDS Best Practice Collection - Key materials. Geneva: UNAIDS.
13. Levin HM. 1983. Cost-effectiveness: a primer. Beverly Hills, CA: Sage Publications.
14. Limão N, Venables A. 2001. Infrastructure, geographical disadvantage, transport costs, and trade. World Bank Economic Review 15: 451-79.
15. Little I, Mirrlees J. 1969. Manual of industrial project analysis in developing countries. Paris: OECD.
16. MacArthur J. 1997. Shadow pricing simplified: Estimating acceptably accurate economic rates of return using limited data. Journal of International Development 9: 367-82.
17. Mason J. 1997. The generalisability of pharmacoeconomic studies. Pharmacoeconomics 11: 503-24.
18. Pepperall J, Mills A, Vaughan P, Watts C, Zwi A. 1994. Costing guidelines for HIV/AIDS prevention strategies. London: London School of Hygiene and Tropical Medicine.
19. Sawert H. 1996. Cost analysis and cost containment in tuberculosis programmes: the case of Malawi. Geneva: World Health Organization, Global Tuberculosis Programme.
20. Sugden R, Williams A. 1978. Principles of practical cost-benefit analysis. Oxford: Oxford University Press.
21. Tan-Torres Edejer T, Baltussen R, Adam T et al. 2003. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization.
22. United Nations Industrial Development Organization. 1972. Guidelines for project evaluation. New York: United Nations.
23. Walker D. 2001. Cost and cost-effectiveness guidelines: which ones to use? Health Policy and Planning 16: 113-21.
24. World Health Organization. 1979. Expanded Programme on Immunization: Costing guidelines. Document EPI/GEN/79.5. Geneva: World Health Organization.
25. World Health Organization. 1988. Estimating costs for cost-effectiveness analysis: Guidelines for managers of diarrhoeal disease control programmes. Document CDD/SER/88.3. Geneva: World Health Organization.
26. World Health Organization. 1998. Safe blood and blood products: costing blood transfusion services. Geneva: World Health Organization.